Overview
Sygnature Discovery is a drug discovery company specializing in computational chemistry, medicinal chemistry, and physical sciences to accelerate the development of novel therapeutics. The company offers integrated services including protein crystallography, DMPK analysis, in vitro bioscience, drug formulation, and synthetic chemistry to support pharmaceutical and biotech clients throughout the drug discovery process.
More in Neurotechnology
Latest industry news
Generative AI Is Closing the Gap on Brain-Computer Interface Accuracy and Resolution
2026-11-11 · Research
Spiking Neural Networks Emerge as a Viable Shield Against Signal Noise in Brain-Computer Interfaces
2026-11-10 · Research
China's Brain-Reading Device Hits 94% Mind-Typing Accuracy Over a Full Day of Use
2026-11-09 · Research
Wearable Brain-Computer Interfaces Are Closer to Mainstream Than You Think
2026-11-08 · Industry
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →